Healthcare industry

Article - 29/10/2018

Aminolipine: formaldehyde-free substitute for preserving biological tissues

For almost 125 years, undertakers as well as physicians in the fields of anatomy and pathology have used formaldehyde to preserve biological tissue and whole cadavers. Yet, formaldehyde is highly toxic and linked to cancer. A team led by Prof. Dr. Bernhard Hirt from the Institute of Clinical Anatomy and Cell Analysis at the University Hospital in Tübingen has developed a formaldehyde-free replacement substance.

Article - 10/10/2018

BABYBE GmbH: Premature babies in contact with mum around the clock

It used to be believed that premature babies needed as much rest as possible. However, studies have since shown that this is not the case at all. According to these studies, the brains of premature babies need to be stimulated 24 hours a day, ideally close to the mother, to ensure healthy development. The Stuttgart-based start-up BABYBE GmbH has developed a special gel mattress that enables babies to perceive their mother’s heartbeat and voice…

Industry report 2018 - 27/09/2018

The healthcare industry – the innovation driver of the 21st century: opportunities and challenges

BIOPRO Baden-Württemberg’s new industry report entitled "The Healthcare Industry 2018: Facts and Figures for Baden-Württemberg" has just been published in both German and English. The topic neatly dovetails with the state’s political activities. An evaluation of the region carried out on behalf of the Baden-Württemberg government has clearly recognised the importance of the healthcare sector as a driver of innovation.

The European Research Council (ERC) awards Starting Grants to support excellent young scientists when they are starting an independent science career. In this year's round of proposals, three scientists from the German Cancer Research Center (DKFZ) have been chosen at once for the prestigious award: Ana Banito, Fabian Erdel and Moritz Mall.

Company profile - 26/07/2018

evid - therapy recommendations at a glance

There are over 700 treatment guidelines in Germany alone, and each is up to several hundred pages long. Can doctors still stay on top of things? A start-up company from Mannheim called evid is developing a software that can retrieve relevant therapy recommendations for individual patients from the huge pile of paperwork. In March 2018, the founding trio won first place of the eHealthForum Freiburg start-up competition.

SHS Gesellschaft für Beteiligungsmanagement has received capital commitments of over €90 million in its fifth fund's first closing. The fifth generation of SHS funds is also focused on the life sciences and medical technology sector, and thus on the growing global healthcare market with innovative and strong players, especially in Germany and Switzerland.

Article - 06/06/2018

Robots for assisting with care and treatment in nursing homes and hospitals

Robotic systems have great potential in the healthcare sector. For example, intelligent care aids, such as robotic technologies, extended care trolleys and lifters make life easier for nursing home and hospital staff. Mobile robots that assist with transport tasks or guiding people can help patients become more independent.

Article - 08/03/2018

Investors wanted: can crowdfunding get the electric walking frame up and running?

If e-bikes make getting around easier, why shouldn't it be possible to apply the same principle to walking frames? That's exactly the question that three young company founders from Stuttgart asked, which led to the development of an electric walking frame called ello. This new walking frame allows users to cope with gradients and kerbs easily and without too much effort.

Article - 07/12/2017

GoSilico: a formula for the industrial purification of biomolecules

“Stop experimenting – GoSilico” is the motto of a young start-up company from Karlsruhe. The founding team of GoSilico GmbH is causing a furore with a simulation software that would make many laboratory experiments obsolete. The chromatographic separation of biomolecules from organisms, samples and cell cultures can be reliably simulated after just a few starter experiments. This saves time, work, material and costs in pharmaceutical development.

Press release - 01/12/2017

Berlin-Brandenburg Academy Prize for Lena Maier-Hein

Lena Maier-Hein from the German Cancer Research Center (DKFZ) helps physicians get better vision during minimally-invasive surgery. Using novel methods of image analysis, she wants to provide additional image information for surgeons. Thus, they can better differentiate tumors from healthy tissue and execute safer surgical tumor therapies. Maier-Hein now receives the Prize of the Berlin-Brandenburg Academy of Sciences and Humanities, which is…

Article - 28/09/2017

Textile implant as herniated disc repair kit

Repairing herniated discs is a clinical need that has still not been met. When the discomfort becomes unbearable, surgery can be performed and the intervertebral disc is generally removed. However, this can further reduce the patients’ quality of life. Scientists at DITF, in cooperation with the Spanish company NEOS Surgery S.L., have developed a textile-based device for treating herniated discs. The device is a minimally invasive “repair kit”…

The Commission welcomes the adoption of its proposal for two Regulations on medical devices which establish a modernised and more robust EU legislative framework to ensure better protection of public health and patient safety.

Article - 31/03/2017

Bosch to enter the medical technology sector – start-up culture meets proven expertise

Many of us have known the Bosch Group mainly as a technology company that is active in the automotive sector. Now, the multinational company is opening up a whole new field of business and is entering the medical technology market with a new subsidiary. Bosch Healthcare Solutions GmbH, which is headquartered in the city of Waiblingen, has developed an innovative breath analysis device that allows asthmatics to measure the severity of airway…

Article - 23/03/2017

CeMIT – professional innovation management for the medical device sector

With the establishment of the Centrum für Medizintechnische Innovationen Tübingen, or CeMIT, the University Hospital of Tübingen is building a bridge between hospitals and medical device companies, which share the aim to develop new and better medical technology products and methods. Partners from small and medium-sized companies are expected to particularly benefit from the services that CeMIT provides and the guidance it can offer in finding…

Press release - 13/12/2016

Early-diagnosis systems from Baden-Württemberg help prevent the spread of drug-resistant pathogens

More and more bacteria are developing resistance to multiple antimicrobial drugs. These multidrug-resistant bacteria can impede the action of common antibiotics via mutations or DNA transfer. More than 30,000 people are infected every year with multidrug-resistant bacteria in German hospitals alone. This could be prevented with appropriate hygiene measures and innovative test systems. Innovative test systems that enable reliable and rapid…

Article - 22/11/2016

Research on the durability and longevity of artificial joints

In Germany alone, several hundred thousand patients are given an artificial hip, knee or shoulder joint every year. Prof. Dr. Jan Philippe Kretzer and his team of researchers in the Laboratory of Biomechanics and Implant Research at the University Hospital in Heidelberg are studying what limits the longevity of implants and how durability can be improved.

High-tech - 20/10/2016

Industry 4.0 in the medical technology and pharmaceutical industry sectors

The digitalisation of industry affects the entire value chain. From individual products to digitising workflows in companies and connecting companies with clients and service providers via the Internet of Things – Industry 4.0 makes completely new manufacturing processes possible and requires new and specific business models.

Article - 01/09/2016

Tailor-made biotech fibres for improved wound dressings

Scientists have developed a biotechnological process to produce bacterial alginate. The alginate quality is highly reproducible, making it suitable for the production of fibre-based medicinal products such as wound dressings.

Company profile - 18/07/2016

mbits imaging GmbH – mobile app in the field of radiology

Trying to get a second opinion from a medical colleague who is at home preparing dinner may be quite a challenge, especially when the colleague does not have access to the necessary image data. This has now become easier in the field of radiology thanks to a mobile app called mRay, which provides a reliable way for radiologists to share medical images on mobile devices.

Company profile - 14/07/2016

neuroloop GmbH: how the manipulation of neuronal information can lower blood pressure

Millions of people worldwide suffer from high blood pressure. However, taking medicines to control high blood pressure does not work for everyone. Dr. Dennis Plachta and Prof. Dr. Thomas Stieglitz from IMTEK have now developed a neurostimulator to control blood pressure. Together with Dr. Michael Lauk, an experienced company founder, the two researchers set up a company called neuroloop, which is funded by Aesculap AG and aims to turn the…

Company profile - 05/07/2016

HS-Analysis GmbH – using digital histology to develop new drugs

The idea of analysing tissue samples automatically sounds more of a pipe dream than anything else. However, it already happens. HS-Analysis GmbH's ability to interpret tissue samples automatically is driving new drug development a decisive step forward.

Article - 23/06/2016

The body’s immune system loosens artificial joints

Hip and knee endoprostheses are not nearly as long-lasting as their natural counterparts. Dr. Ulrike Dapunt from the University Hospital Heidelberg’s Department of Orthopaedics and Traumatology has now discovered that it is not the bacterial activity or secretions that lead to the degradation of bone during chronic inflammation, but rather local host defence mechanisms.

CorTec just closed a new investment that will support bringing new personalized therapies for neurological diseases to patients. With Mangold Invest a new investor could be attracted who wants to go along that way with the young medical engineering company located in Freiburg. Equally convinced of the success of this project are the previous investors who are participating in this round of financing.